Like IL6, IL10 is strongly associated with COVID-19 severity (18, 48, 49), and some prior reports suggest that it may paradoxically enhance inflammation in such settings [IL10 enhances endotoxemia (50) and induces IFNγ in patients with Crohn’s disease (51)]. This evidence concerns the gene IL6 and COVID-19.